Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9

Fig 5

Metabolism assays using recombinant CYP2C9 supersomes for the identification of CYP2C9-produced metabolites.

The suggested metabolite structures for abemaciclib, tarafenacin, cloperidone and vatalanib are shown.